Skip to content
Disclosery

QIMING U.S. VENTURES MANAGEMENT, LLC

Follow

13F filer, CIK 1909617, BELLEVUE, WA

QIMING U.S. VENTURES MANAGEMENT, LLC reported $23,102,786 across 6 holdings for the quarter ended 2025-03-31, in a 13F-HR filed 2025-05-15.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001415889-25-013135

Period
2025-03-31
Reported value
$23.1M
Holdings
6
Top 10 weight
100%
New
0
Sold out
0

Holdings, Q1 2025

Share positions as resolved from 13F-HR 0001415889-25-013135, largest first. % of portfolio is the value over $23,102,786, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
Tourmaline Bio IncTourmaline Bio IncQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: 641,691 shares; 2024Q1: 741,691 shares; 2024Q2: 741,691 shares; 2024Q3: 741,691 shares; 2024Q4: 741,691 shares; 2025Q1: 741,691 shares 741,691$11.3M48.83%0
KRROKORRO BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: 368,085 shares; 2024Q1: 368,085 shares; 2024Q2: 368,085 shares; 2024Q3: 368,085 shares; 2024Q4: 368,085 shares; 2025Q1: 368,085 shares 368,085$6.41M27.74%0Timeline
JSPRJASPER THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: not reported; 2024Q1: 928,964 shares; 2024Q2: 928,964 shares; 2024Q3: 928,964 shares; 2024Q4: 928,964 shares; 2025Q1: 928,964 shares 928,964$3.99M17.29%0Timeline
HILLEVAX INCHILLEVAX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: 558,923 shares; 2024Q1: 558,923 shares; 2024Q2: 558,923 shares; 2024Q3: 558,923 shares; 2024Q4: 372,615 shares; 2025Q1: 372,615 shares 372,615$540K2.34%0
VTYXVENTYX BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: 686,370 shares; 2024Q1: 412,225 shares; 2024Q2: 412,225 shares; 2024Q3: 412,225 shares; 2024Q4: 412,225 shares; 2025Q1: 412,225 shares 412,225$474K2.05%0Timeline
KZRKEZAR LIFE SCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: not reported; 2024Q1: not reported; 2024Q2: not reported; 2024Q3: not reported; 2024Q4: 82,871 shares; 2025Q1: 82,871 shares 82,871$404K1.75%0Timeline

How Q1 2025 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001415889-25-013135 base2025-05-15acceptance time not in the bulk data set